Pathogenesis and immunity of Clostridium perfringens type C enteritis in swine.
D000818:Animals; D000992:Antitoxins / Q000008:administration & dosage; D003015:Clostridium Infections / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D003016:Clostridium perfringens / Q000276:immunology*; D003126:Colostrum / Q000276:immunology; D004751:Enteritis / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D007110:Immunity, Active; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D009336:Necrosis / Q000150:complications / Q000473:pathology / Q000662:veterinary; D013552:Swine; D013553:Swine Diseases / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D014121:Toxoids / Q000008:administration & dosage
D000992:Antitoxins; D014121:Toxoids